Add to ORKGBackground. Plasma lipoprotein (a) [Lp(a)] has been shown to be a risk factor for atherosclerosis in numerous studies. However, the catabolism of this lipoprotein is not very clear. We and others have shown that Lp(a) is excreted into urine in the form of fragments. Lp(a) has also been shown to exist in a low-density non-lipoprotein (LDL)-bound form. Since Lp(a) is increased in all forms of kidney disease with reduced excretory kidney function and decreased excretion of apo(a) fragments could be partially responsible for this increase, we investigated the relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function. Methods. Plasma Lp(a), non-LDL-bound apo(a) and urinary apo(a) fra...
Lipoprotein(a) (Lp(a)) and its measurement, structure and function, the impact of ethnicity and envi...
Animal experiments show that the kidney contributes to apolipoprotein (apo) A-I catabolism. We teste...
Lipoprotein (a) levels in those with high molecular weight apo (a) isoforms may remain low in a sign...
Background. Plasma lipoprotein (a) [Lp(a)] has been shown to be a risk factor for atherosclerosis in...
Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease. Rapi...
Plasma levels of lipoprotein(a) (Lp(a)), an atherogenic particle, are elevated in kidney disease, wh...
To investigate the relation between renal function and concentrations of iipoprotein(a) [Lp(a)] in s...
Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failur...
Background. Atherosclerotic diseases are a major cause of death in patients with renal failure. Incr...
Apolipoprotein(a) [apo(a)] is a plasma glycoprotein that is highly polymorphic in size due to differ...
Lipoprotein(a) (Lp(a)) consists of a low-density lipoprotein-like particle and a covalently linked h...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Lipoprotein(a) (Lp(a)) consists of a low-density lipoprotein-like particle and a covalently linked h...
OBJECTIVE: To examine the influence of the nephrotic syndrome on lipoprotein(a) [Lp(a)], a plasma li...
.Objective: To evaluate the distribution pattern of apolipoprotein(a) [Apo(a)] phenotypes in Koreans...
Lipoprotein(a) (Lp(a)) and its measurement, structure and function, the impact of ethnicity and envi...
Animal experiments show that the kidney contributes to apolipoprotein (apo) A-I catabolism. We teste...
Lipoprotein (a) levels in those with high molecular weight apo (a) isoforms may remain low in a sign...
Background. Plasma lipoprotein (a) [Lp(a)] has been shown to be a risk factor for atherosclerosis in...
Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease. Rapi...
Plasma levels of lipoprotein(a) (Lp(a)), an atherogenic particle, are elevated in kidney disease, wh...
To investigate the relation between renal function and concentrations of iipoprotein(a) [Lp(a)] in s...
Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failur...
Background. Atherosclerotic diseases are a major cause of death in patients with renal failure. Incr...
Apolipoprotein(a) [apo(a)] is a plasma glycoprotein that is highly polymorphic in size due to differ...
Lipoprotein(a) (Lp(a)) consists of a low-density lipoprotein-like particle and a covalently linked h...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Lipoprotein(a) (Lp(a)) consists of a low-density lipoprotein-like particle and a covalently linked h...
OBJECTIVE: To examine the influence of the nephrotic syndrome on lipoprotein(a) [Lp(a)], a plasma li...
.Objective: To evaluate the distribution pattern of apolipoprotein(a) [Apo(a)] phenotypes in Koreans...
Lipoprotein(a) (Lp(a)) and its measurement, structure and function, the impact of ethnicity and envi...
Animal experiments show that the kidney contributes to apolipoprotein (apo) A-I catabolism. We teste...
Lipoprotein (a) levels in those with high molecular weight apo (a) isoforms may remain low in a sign...